Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Stomach Neoplasms 4Thyroid Neoplasms 2Oropharyngeal Neoplasms 2NSCLC 2Lung Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thymic epithelial tumor 1Spinal Metastasis 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Recurrence 1Prostatic Neoplasms 1Pilonidal Sinus 1Pathologic Complete Response 1Pancoast Syndrome 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Mouth Neoplasms 1Microsatellite Instability 1

Interventions

apatinib 1Surgical Procedures, Operative 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thymic epithelial tumor × Surgical Procedures, Operative × Clear all
NCT07383142 2026-02-06

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)

Shanghai Zhongshan Hospital

Phase NA Not yet recruiting
202 enrolled

Thymic epithelial tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡